Combined Oral Contraceptives (COC)
Absolute Contraindications
- Current or history of thromboembolic events
- Active breast cancer
- Severe liver disease
Main Side Effects
- Nausea, headaches, mood changes
- Increased thromboembolic risk
Main Interactions
- Enzyme inducers (e.g., rifampicin, carbamazepine) reduce efficacy
Main Monitoring Requirements
- Blood pressure annually
Pregnancy & Breastfeeding
- Avoid during breastfeeding